Skip to content

Dr. Birgit Mispelaere

Active Private limited companyfounded 2017active for 9 yearsLeiseleveld 57, 8200 BrugesKBO/BCE: BE 0672.526.833

Lifetime

9 annual accounts with figures on one time axis
peak of €293,074 in 2023
€188,380▼ 23.4%
peak of €196,164 in 2023
€130,874▼ 22.0%
peak of €753,613 in 2025
€753,613▲ 0.1%
€345,136▲ 59.0%
Board1 name since 2017
1 director
Documentsfilings and deeds
25-06-202636 days before the deadline
2025micro format
Gross margin from €246,019 to €188,380Dividend €130,000Debts from €217,002 to €345,136Cash from €339,900 to €633,824

Key points

from the 2025 annual accounts

Equity

€753,613 ▲ 0.1%
752,7392024+130,874Profit-130,000Dividend753,6132025

Dr. Birgit Mispelaere paid out €130,000 in dividends. That is 99% of the 2025 profit.

Filings

9 annual accounts 5 late
AprilJune31 JulyOctober20202025

The 2022 accounts came in latest, 31 days after the end of the period.

Position in the sector

€753,613

More equity than 89% of companies in human health. The sector median is €125,188, over 21,399 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 6,787 companies had the same profile as Dr. Birgit Mispelaere has now. Each dot stands for 17 companies, two years later.

96.7%
were still trading
2.7%
stopped another way
0.6%
went bankrupt
  • Small
  • 5 to 10 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 498,062 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 6,787 companies, not a prediction for Dr. Birgit Mispelaere. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • all the sharesdeed of 16-01-2024
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0672526833
changes role from manager to director holds all the shares · Discharge granted to · General meeting of 28-12-2023 · Gazette deed
Publication in the Belgian Official Gazette Gazette deed
Incorporation Founding capital of €18,600, 186 shares · Founded by · appointed as manager · published on 10-03-2017 · Gazette deed
All 17 events

Comparable companies

same main activity, similar in size and age
Company
Dr. Birgit Mispelaere Bruges €1.1m €188,380 68.6% -
Dr. Nima Tabrizi, urgentiearts Dilbeek €1.1m €180,696 87.3% -
Dr. DE BLOCK Londerzeel €1.1m €177,675 49.3% -
Fides Dermatologie Bierbeek €1.0m €193,142 24.8% -
DR. VERBEERST LORENTZ Nazareth-De Pinte €1.2m €174,376 23.7% -
DR. VAN DER ENDT J Ixelles €1.2m €206,118 98.0% -
Dr. Cornelis Natasha Zedelgem €1.1m €194,863 62.8% -

These companies have the same main activity as Dr. Birgit Mispelaere: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €1m and €1.2m, founded between 2015 and 2018.

Official details

Source: KBO
Status
Active since 08-03-2017Normal situation
Activity
Specialist medical practiceNACE 86220and 1 other
Financial year end
31 December
Peppol
Reachable since 16-01-2026
Company details

Annual accounts 2025

≈ €350,000estimated
€1.1m▲ 13.3%
Filing
Filed on 25-06-2026, 36 days before the end of the filing period
Financials

Insights on Dr. Birgit Mispelaere

Dr. Birgit Mispelaere files the micro format. That format states no turnover. The gross margin rose from €58,920 in 2017 to €188,380 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Dr. Birgit Mispelaere

What is the company number of Dr. Birgit Mispelaere?
The company number of Dr. Birgit Mispelaere is 0672.526.833. The VAT number is the same number with BE in front: BE 0672.526.833.
Where is Dr. Birgit Mispelaere based?
The registered office is at Leiseleveld 57, 8200 Bruges.Company details
What does Dr. Birgit Mispelaere do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Dr. Birgit Mispelaere?
Dr. Birgit Mispelaere is a private limited company (BV).
When was Dr. Birgit Mispelaere founded?
Dr. Birgit Mispelaere was founded on 08-03-2017.
Is Dr. Birgit Mispelaere still active?
Yes, Dr. Birgit Mispelaere is an active enterprise in the KBO register.
What is the turnover of Dr. Birgit Mispelaere?
The turnover in financial year 2025 is about €350,000. This figure is estimated from the gross margin of €188,380 and 40 comparable companies (NACE 86220). It probably lies between €300,000 and €470,000.Financials
Is Dr. Birgit Mispelaere profitable?
In financial year 2025, Dr. Birgit Mispelaere made a profit of €130,874.
Where can I find the annual accounts of Dr. Birgit Mispelaere?
Dr. Birgit Mispelaere filed 9 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. Birgit Mispelaere due?
Dr. Birgit Mispelaere must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.